Trial intelligence / Profile preview

Follow-Up of Inhaled Nitric Oxide in Premature Infants

NCT00390065Phase 4Completed

Sponsor
Maternité Régionale Universitaire
Start
Oct 2006
Primary completion
Jun 2009
Modality
DNA Intercalators/Alkylators, Inhalation Devices
Countries
1
01

Overview

A Phase 4 trial of nitric oxide in respiratory distress syndrome (RDS), hypoxemic respiratory failure, sponsored by Maternité Régionale Universitaire. Started Oct 2006; status: completed.

02

Drugs

nitric oxide
03

Conditions

respiratory distress syndrome (RDS)hypoxemic respiratory failure

Beyond the preview

Go deeper on NCT00390065.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00390065.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call